Ignite Creation Date:
2025-12-24 @ 9:49 PM
Ignite Modification Date:
2026-01-02 @ 3:19 AM
Study NCT ID:
NCT06608732
Status:
RECRUITING
Last Update Posted:
2024-11-05
First Post:
2024-09-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission.
Sponsor:
Institute of Hematology & Blood Diseases Hospital, China
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-08-01
Start Date Type:
ACTUAL
Primary Completion Date:
2028-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-09-10
First Submit QC Date:
None
Study First Post Date:
2024-09-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-04
Last Update Post Date:
2024-11-05
Last Update Post Date Type:
ACTUAL